FDA Regulatory Books and PCR Memoirs: End-of-Summer Picks with Nick and Nigel

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

FDA Regulatory Books and PCR Memoirs: End-of-Summer Picks with Nick and Nigel

Topic: Bio Break
YouTube video thumbnail

In this Bio Break episode, Nick Allan and Nigel Syrotuck share their end-of-summer reading list, featuring FDA regulatory books and PCR memoirs. From navigating regulatory hurdles to celebrating groundbreaking discoveries, their choices show how science reading can be both educational and entertaining.

FDA Regulatory Reading

Nigel highlights Innovation Breakdown, a book that examines the regulatory processes of the FDA. He explains that while the FDA ensures medical devices are safe and effective, the pathway to approval can be costly and complex. For innovators, this book illustrates both the challenges and safeguards within the FDA system.

PCR Discovery Through Storytelling

Nick’s pick is Dancing Naked in the Minefield by Kary Mullis. This memoir tells the story of polymerase chain reaction (PCR), a discovery that transformed molecular diagnostics. Mullis’s unusual personality and candid storytelling make the book as engaging as it is informative. PCR continues to influence lab testing worldwide, and Nick reflects on its lasting importance.

End-of-Summer Science Picks

Together, Nick and Nigel offer a mix of perspectives: FDA regulatory books that reveal systemic barriers and protections, and scientific memoirs that celebrate creativity and discovery. Their end-of-summer picks capture how reading can deepen our understanding of both process and innovation.

From FDA regulations to PCR breakthroughs, these end-of-summer reads show how science books can spark insight and inspiration.

Enjoying Bio Break? Sign up to get new episodes sent to your inbox.

Subscribe to Bio Break
Diagram showing medical device at the center connected to clinicians, patients, and regulatory bodies with text 'Who are we designing for?' highlighting stakeholder mapping in MedTech design.

Understanding Medical Device Stakeholders

Every phase of a device’s life cycle involves different people with distinct needs—from clinicians and patients to service technicians and regulatory bodies.

A fluorescent protein assay sample glows under UV light as part of medical device cleaning validation testing.

Fluorescent Protein Assay Testing in Medical Devices

Nick Allan and Nigel Syrotuck explain how a fluorescent protein assay helps engineers measure contamination and cleaning performance in medical devices.

Engineer assembling electronic components during medical device design transfer process.

Bridging the Design-to-Manufacturing Gap in Medical Devices

Your team is ready for design validation. The prototype performs well, test plans are in motion, and everything points to a smooth handoff to manufacturing. Then your partner calls with bad news: they can’t build the device as designed.

Contract Manufacturer Rejection - Engineering team reviews early-stage medical device design and manufacturability during a design transfer meeting at StarFish Medical.

When the CM Says No: What to Do When Your Contract Manufacturer Rejects Your Early-Stage Build

You’ve cleared the toughest engineering hurdles and proven your design works. Then, just as you prepare to scale, your contract manufacturer turns you down.